Targeted Therapy Options for Treatment of Bone Metastases; Beyond Bisphosphonates

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|27|3015-3027

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.27, 2010-09, pp. : 3015-3027

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bisphosphonates as Treatment of Bone Metastases

By  

Current Pharmaceutical Design, Vol. 16, Iss. 11, 2010-04 ,pp. : 1262-1271

Bentham Science Publishers

Access to resources Recommend Favorite

Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases

By  

Current Cancer Drug Targets, Vol. 10, Iss. 7, 2010-11 ,pp. : 649-659

Bentham Science Publishers

Access to resources Recommend Favorite

New Bisphosphonates in the Treatment of Bone Diseases

By Gatti D.   Adami S.  

Drugs & Aging, Vol. 15, Iss. 4, 1999-10 ,pp. : 285-296

Adis International

Access to resources Recommend Favorite

Prevention and Treatment of Bone Metastases

By  

Current Pharmaceutical Design, Vol. 16, Iss. 27, 2010-09 ,pp. : 2998-3006

Bentham Science Publishers

Access to resources Recommend Favorite

Bone Metastases and Non-Small Cell Lung Cancer: From Bisphosfonates to Targeted Therapy

By  

Current Medicinal Chemistry, Vol. 19, Iss. 32, 2012-11 ,pp. : 5524-5535

Bentham Science Publishers

Access to resources Recommend Favorite